Navigation Links
2014 Beauty Breakthrough -- Age-Defying Laser brings professional, anti-aging treatments into the home for the first time
Date:1/13/2014

DUBLIN, Calif., Jan. 13, 2014 /PRNewswire/ -- Tria Beauty, Inc., the world leader in at-home laser skincare treatments, announced today the launch of its Age-Defying Laser in the United States.  The Age-Defying Laser was recently cleared by the FDA for the treatment of multiple signs of facial aging and is appropriate for all skin types and tones.

This newest skincare laser from Tria is clinically proven to treat multiple signs of facial aging as well as comparable dermatologist treatments and delivers superior results compared to traditional at-home anti-aging regimens. In extensive clinical studies performed by leading physicians:

  • 95% of study participants saw significant improvement in overall appearance
  • 92% agree the Age-Defying Laser is more effective than creams and serums
  • 85% reported more radiant, youthful looking skin
  • 76% experienced significant reduction in fine lines and wrinkles

Beginning today, the Age-Defying Laser is available for sale at www.triabeauty.com for $495 and comes with a free gift including, Age-Defying Priming Cleanser and Finishing Serum, which are specially formulated to prep skin for laser treatments and soothe and hydrate treated skin. The Age-Defying Laser will also be launching in February at Barneys, Bloomingdale's and Sephora stores across the country. 

"This new product launch represents a key growth milestone for Tria - our entry into the anti-aging skincare category, the largest and fastest growing segment of prestige beauty.  Continuing to launch transformative skincare products like the Age-Defying Laser and expanding distribution with key partners like Sephora will ensure Tria continues its year-over-year, double-digit growth and further cements our brand's leadership position in the skincare category" stated '/>"/>

SOURCE Tria Beauty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harmless Beauty Mark or Melanoma? A Painless New Way to Find Out
2. Cynosure Announces Successful Settlement of Patent Infringement Lawsuits Against Tria Beauty
3. Syneron Medical And Unilever Ventures Create Iluminage Beauty, A Global Joint Venture In Home Beauty Devices
4. Synerons elure Brings Home Allure Magazines Best of Beauty Award, for the Third Consecutive Year
5. MEDIFIRST SOLUTIONS, INC. To Exhibit At The Orlando International Beauty Show
6. Celebrity Beauty Expert Dishes on Nonsurgical "Facelift" Secret
7. Tria Beauty, Inc. and Ulta Announce New Retail Partnership
8. Maxilip Lip Plumper Named CEW Beauty Insiders Choice Awards 2013 Finalist
9. Tria Beauty, Inc. and Sephora Announce New U.S. Retail Partnership
10. Tria Beauty, Inc. Announces Partnership with Jenny McCarthy
11. Tria Beauty Ranked #45 on the San Francisco Business Times Fast 100 List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" ... company, is delighted to announce its financial results ... which includes revenue for three months of $2,180,276 ... from advanced wound care product sales for the ... 24% to $1,742,672 compared to $1,400,065 for the ...
(Date:5/29/2015)... 2015  Epic Sciences announced today that the company ... castrate resistant prostate cancer patients, at the 2015 ... Oncology. This application expands the investigational utility of ... platform to characterize circulating tumor cell (CTC) genomic ... have heterogeneous clonal CTC populations harboring separate genetic ...
(Date:5/29/2015)... , May 29, 2015  World-renowned prostate surgeon and New ... on the benefit of MR/Ultrasound Fusion-Guided Biopsy for ... Prostate Cancer Center at Lenox Hill Hospital is ... System in New York City . We,ve ... risk prostate cancers. The use of an MRI makes for ...
Breaking Medicine Technology:Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
(Date:5/29/2015)... North Carolina (PRWEB) May 29, 2015 ... confirmed that the newest Red Hot & Blue restaurant at ... business on Thursday, May 7, 2015. “The Red Hot & ... center for 18 years, but we have moved to a ... are now in the middle of all the activities on ...
(Date:5/29/2015)... May 29, 2015 Johnson & ... a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement ... due to his use of the antipsychotic medication. ... selected for the third bellwether trial to involve ... litigation underway in Pennsylvania’s Philadelphia Court of Common ...
(Date:5/29/2015)... May 29, 2015 World Patent Marketing, ... announces that it has signed a 10 year licensing ... that aims to let people learn about any topic ... time. , "This is an exciting day for World ... Scott J. Cooper, CEO and Creative Director of World ...
(Date:5/29/2015)... May 29, 2015 The print component ... a circulation of approximately 250,000 and an estimated readership ... a vast social media strategy, and across a network ... the digital version of the campaign, click here. ... print publication. Inside, the actress, model and producer details ...
(Date:5/29/2015)... May 29, 2015 The campaign focuses ... as a number of specific concerns within, including the ... and mental health in the workplace. We are encouraged ... The campaign also brings special focus to people living ... speak up and seek help from healthcare professionals and ...
Breaking Medicine News(10 mins):Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2
... Regions, These Markets Remain Stable, According to New ... HealthLeaders-InterStudy, a leading provider of managed care ... many regions of the country have halted because ... in Buffalo, N.Y., and Baton Rouge, La., are ...
... Calif., Jan. 26 Doctors at the,Northwoods Cancer ... patients,using new RapidArc radiotherapy technology from Varian Medical ... a retired machinist fighting prostate cancer, is,among the ... speed and accuracy of,RapidArc, which delivers image-guided intensity-modulated ...
... Jan. 26 ChromaDex Corporation, (OTC Bulletin Board: ... contract research, announced today that Nutrition Business Journal, ... care magazine, selected the Company as one of ... its achievement in setting stevia standards as part ...
... will add new technology to help ORBIS train doctors ... ORBIS International , a nonprofit ... donated PASCAL photocoagulator as part of a new partnership ... to treat a variety of retinal diseases, PASCAL dramatically ...
... Jan. 26 FluoroPharma Inc., a company ... Positron Emission Tomography (PET) market, announced today ... Office issued U.S. Patent No. 7,438,891, covering ... F18 labeled 2-fluorodeoxy-D-glucose (FDG). This patent, exclusively ...
... N.J., Jan. 26 Quest Diagnostics Incorporated (NYSE: ... of diagnostic testing, information and services, announced that ... in share repurchases. The company had approximately 190 ... 2008."This repurchase program demonstrates confidence in our performance ...
Cached Medicine News:Health News:Hospital Expansions in Buffalo, N.Y., and Baton Rouge, La., Contribute to Recession Resilience 2Health News:Hospital Expansions in Buffalo, N.Y., and Baton Rouge, La., Contribute to Recession Resilience 3Health News:A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 2Health News:A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 3Health News:ChromaDex Awarded Nutrition Business Journal Scientific Achievement 2Health News:ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica 2Health News:ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica 3Health News:ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica 4Health News:FluoroPharma Obtains US Patent for Imaging Cardiovascular Plaque using FDG 2Health News:Quest Diagnostics' Board Authorizes $500 Million in Share Repurchases 2
... 3Z slit lamp is designed to for ... ready slit lamp offers the popular horizontal ... to the ReSeeVit family of slit lamps ... market to capture clear, crisp digital images ...
... system combines continuous access, random ... a broad testing menu. AxSYM ... clinical laboratories to process a ... as well as adding tests ...
... an automated, multiparametric immunoassay system. ... stores the calibration in the ... cost-per-patient result. Plus, ease ... labor cost is also optimized. ...
... AIA-1800 is the newest and most advanced ... The AIA-1800 launches with a full ... markers, thyroid, reproductive, cardiac, and anemia assays. ... throughput, bar-coded primary tube sampling, auto dilution, ...
Medicine Products: